4//SEC Filing
Matis Louis 4
Accession 0001562180-18-001253
CIK 0001583648other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:16 PM ET
Size
5.6 KB
Accession
0001562180-18-001253
Insider Transaction Report
Form 4
Matis Louis
SVP, Chief Development Officer
Transactions
- Award
Stock Options (Right to buy)
2018-02-20+100,000→ 100,000 totalExercise: $8.56Exp: 2028-02-20→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on January 1, 2019 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.
Documents
Issuer
PIERIS PHARMACEUTICALS, INC.
CIK 0001583648
Entity typeother
Related Parties
1- filerCIK 0001650991
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:16 PM ET
- Size
- 5.6 KB